Related by context. All words. (Click for frequent words.) 74 preoperative chemotherapy 73 androgen deprivation 73 radiotherapy RT 72 adjuvant radiotherapy 72 postoperative chemotherapy 71 5FU 71 external beam radiotherapy 71 radical nephrectomy 71 biochemical recurrence 71 adjuvant radiation 71 neoadjuvant chemotherapy 71 pCR 70 chemoradiotherapy 70 cystectomy 70 androgen suppression 70 distant metastases 70 neoadjuvant 70 radical prostatectomy RP 70 locoregional recurrence 69 chemoradiation therapy 69 lymphadenectomy 69 ALND 69 advanced adenomas 69 TURP 69 PSA nadir 69 intravesical therapy 69 clinically localized prostate 69 debulking surgery 69 GnRH agonists 68 adjuvant therapy 68 #Gy 68 chemoradiation 68 endoscopic resection 68 tumor resection 68 5-FU/LV 68 cytoreductive surgery 68 contralateral breast 68 nephrectomy 68 PCa 68 transurethral resection 68 endometrial carcinoma 68 locoregional 68 ABVD 68 PSADT 68 axillary dissection 68 adrenalectomy 68 biochemical relapse 68 cytoreduction 68 chemoembolization 68 neoadjuvant therapy 68 total thyroidectomy 67 pT3 67 TACE 67 FOLFOX4 67 serum testosterone 67 thromboembolic events 67 lymph node dissection 67 operable breast cancer 67 mycophenolate mofetil 67 radical prostatectomy 67 pelvic lymphadenectomy 67 Radical prostatectomy 67 adjuvant chemotherapy 67 dose dexamethasone 67 androgen ablation 67 goserelin 67 androgen suppression therapy 66 trabeculectomy 66 colorectal liver metastases 66 nonmetastatic prostate cancer 66 renal tumors 66 nephron sparing surgery 66 P = .# 66 tamoxifen therapy 66 AVODART 66 axillary node dissection 66 pT2 66 hepatic metastases 66 liver resection 66 radical cystectomy 66 octreotide LAR 66 histologically confirmed 66 androgen deprivation therapy 66 epirubicin 66 advanced adenoma 66 radioiodine therapy 66 concurrent chemoradiation 66 CIN2 + 66 LHRH agonists 66 fluorouracil 66 tumor recurrence 66 Adjuvant chemotherapy 66 lumbar spine BMD 66 beta blocker therapy 66 CR nPR 66 clodronate 66 tamsulosin 66 doxorubicin docetaxel 65 recurrent VTE 65 Doxil ® 65 median PFS 65 hip BMD 65 orchiectomy 65 hematologic toxicity 65 pneumonectomy 65 beam radiotherapy 65 GnRH agonist 65 chlorambucil 65 metastatic RCC 65 MACCE 65 flutamide 65 HER2 negative 65 atypical hyperplasia 65 graft occlusion 65 mg kg dose 65 TURBT 65 CCyR 65 androgen blockade 65 F FDG PET 65 post operatively 65 iodixanol 65 preoperative radiotherapy 65 severe neutropenia 65 DAPT 65 recurrent prostate cancer 65 parathyroidectomy 65 docetaxel chemotherapy 65 cytotoxic therapy 65 WBRT 65 invasive carcinomas 65 carboplatin paclitaxel 65 ALT elevation 65 cisplatin chemotherapy 65 radiochemotherapy 65 cGy 65 HoLEP 65 paclitaxel eluting stents 65 postoperative radiotherapy 65 Flu Cy 65 gemcitabine carboplatin 65 HGPIN 65 bilateral oophorectomy 65 DMARD 65 fallopian tube carcinoma 65 NMIBC 65 timepoints 65 surgical excision 65 liver metastasis 65 nodal metastases 65 resected 65 sentinel lymph node biopsy 65 lymph node involvement 65 mammographic density 64 rebleeding 64 dose cytarabine 64 serum concentrations 64 adenoma recurrence 64 papillary thyroid carcinoma 64 HBeAg seroconversion 64 anastrozole 64 lymph node metastasis 64 asymptomatic carotid stenosis 64 SLNB 64 perioperative mortality 64 cranial irradiation 64 μmol L 64 lobectomy 64 adjuvant therapies 64 methotrexate therapy 64 postoperative complication 64 plus medroxyprogesterone acetate 64 neoadjuvant treatment 64 platelet reactivity 64 serum calcium levels 64 conformal radiotherapy 64 thyroglobulin 64 basal cell carcinoma BCC 64 dosage regimens 64 contralateral breast cancer 64 resectable 64 FIRMAGON 64 postoperative mortality 64 intraperitoneal chemotherapy 64 IELT 64 angiographic restenosis 64 TAVR 64 sonographically 64 ablative therapy 64 reintervention 64 intravenous bisphosphonates 64 aromatase inhibitor therapy 64 adnexal mass 64 CsA 64 postoperative morbidity 64 oncologic outcomes 64 imatinib therapy 64 daunorubicin 64 relapsed MM 64 revascularizations 64 azacitidine 64 FDG uptake 64 CIN3 64 placebo dexamethasone 64 endometrial thickness 64 gadolinium enhanced 64 prostate cancer CaP 64 #.#ng/ml 64 Kaplan Meier analysis 64 adjuvant tamoxifen 64 prostate cancer CRPC 64 preoperatively 64 liver metastases 64 TNF antagonist 64 EUS FNA 64 bolus dose 64 antiangiogenic therapy 64 antithymocyte globulin 64 reinfarction 64 peritoneal carcinomatosis 64 cervical intraepithelial neoplasia 64 periprocedural 64 endometrial hyperplasia 63 curative resection 63 adriamycin 63 node dissection 63 SUVmax 63 paroxysmal AF 63 cytoreductive nephrectomy 63 ipsilateral stroke 63 Peg IFN 63 hormonal therapy 63 colorectal adenoma 63 definite stent thrombosis 63 extracapsular extension 63 mCi 63 receiving VICTRELIS 63 node metastases 63 trastuzumab 63 IM progesterone 63 euthyroid 63 BEACOPP 63 Thal Dex 63 pancreatic adenocarcinoma 63 neoplasia 63 standard chemotherapy regimens 63 prostate adenocarcinoma 63 unresectable tumors 63 fibrinolysis 63 intima media thickness 63 perioperatively 63 plus dexamethasone 63 underwent resection 63 methotrexate monotherapy 63 mitoxantrone 63 idarubicin 63 zoledronic acid 63 corifollitropin alfa 63 Lenalidomide 63 XELOX 63 p = #.# [003] 63 pamidronate 63 RALP 63 preoperative PSA 63 HER2 positive tumors 63 perioperative complications 63 comparator arm 63 metastatic gastric 63 axillary lymph node dissection 63 ductal breast cancer 63 mg/m2 dose 63 urothelial carcinoma 63 epithelial ovarian cancer 63 abacavir lamivudine 63 LUTS 63 intestinal metaplasia 63 leiomyomas 63 recanalization 63 nadolol 63 hypogonadal 63 paclitaxel carboplatin 63 adjunctive placebo 63 IFN alfa 63 cytotoxic chemotherapy 63 low dose cytarabine 63 tirofiban 63 resection 63 HSCT 63 adjuvant hormonal therapy 63 LHRH agonist 63 prostate carcinoma 63 bilateral orchiectomy 63 LVEF 63 colectomy 63 chemotherapeutic regimens 63 epirubicin cyclophosphamide 63 adenoma 63 rFSH 63 fulvestrant 63 hepatectomy 63 Mitomycin C 63 moderate renal impairment 63 decitabine 63 ALA PDT 63 unfractionated heparin 63 nonfatal MI 63 mitomycin C 63 hepatic resection 63 Neoadjuvant 63 grade cervical intraepithelial 63 tibolone 63 certolizumab 63 T1a 63 metastatic disease 63 NNT = 63 azathioprine 63 DMARD therapy 63 crossclamp 63 surgical debulking 63 undetectable HBV DNA 63 sirolimus eluting stents 63 everolimus eluting stents 63 cyclophosphamide 63 vinorelbine 63 dyspareunia 63 docetaxel Taxotere ® 63 thoracoscopic lobectomy 63 BRCA1 mutation carriers 63 IV bisphosphonates 63 colorectal cancer liver metastases 63 TT genotype 63 FOLFOX 63 revascularization procedures 63 cervical lesions 63 Fludara 63 nonoperative 63 IOP lowering 63 intravitreal injections 63 DOXIL 63 PASI scores 63 hemorrhagic complications 63 TRUS 63 gemcitabine cisplatin 63 univariate analysis 63 dose atorvastatin 63 sorafenib Nexavar 63 baseline LDH 63 pelvic lymph node dissection 62 cervical carcinoma 62 colorectal carcinoma 62 etoposide 62 dacarbazine 62 nonoperative treatment 62 breast carcinoma 62 prednisone prednisolone 62 variceal hemorrhage 62 % CI #.#-#.# [003] 62 pelvic radiotherapy 62 grade squamous intraepithelial 62 detrusor overactivity 62 corticosteroid therapy 62 achieved ACR# 62 chemotherapy docetaxel 62 FOLPI 62 intravenous cyclophosphamide 62 lymph node removal 62 BRCA2 mutation carriers 62 esophagectomy 62 bone metastases 62 KRAS mutations occur 62 binary restenosis 62 #F FDG 62 exemestane 62 CHOP chemotherapy 62 interferon ribavirin 62 oral allopurinol 62 APTIVUS r 62 LNG IUS 62 luteinizing hormone releasing 62 antiandrogen 62 eptifibatide 62 adenomatous 62 ductal cancer 62 microdebrider 62 dutasteride 62 metastatic malignant 62 HBeAg negative 62 CI #.#-#.# [001] 62 gemcitabine Gemzar 62 allogeneic SCT 62 T2 lesions 62 transurethral 62 LV dysfunction 62 ALT flares 62 distant metastasis 62 virological failure 62 chronic GVHD 62 doxazosin 62 coronary stenosis 62 cisplatin vinorelbine 62 CC genotype 62 nonmetastatic 62 ultrasonographic 62 prostatectomy 62 adenomatous polyps 62 Pred Forte 62 invasive coronary angiography 62 alteplase 62 ARB telmisartan 62 Elitek 62 axillary node 62 Folfox 62 dexamethasone Decadron 62 invasive carcinoma 62 thromboprophylaxis 62 vaginal hysterectomy 62 antiandrogens 62 bicalutamide 62 T2DM 62 bioavailable testosterone 62 gemcitabine chemotherapy 62 5-fluorouracil/leucovorin 62 lymph node metastases 62 β blockers 62 bisphosphonate therapy 62 R0 resection 62 stage IIIB 62 ibandronate 62 FOLFIRI 62 ICD implantation 62 thiazide diuretic 62 irbesartan 62 locoregional disease 62 metastatic lesions 62 platelet inhibitor 62 underwent radical prostatectomy 62 dose melphalan 62 liver histology 62 colorectal neoplasms 62 estramustine 62 cisplatin 62 pulmonary resection 62 thyroid carcinoma 62 CYPHER Stent 62 virologic failure 62 vertebral fracture 62 cilostazol 62 pegylated liposomal doxorubicin 62 serum phosphate 62 complete cytogenetic response 62 mRCC 62 tPSA 62 Platinol ® cisplatin 62 coadministration 62 squamous intraepithelial lesions 62 neoplastic lesions 62 ASCUS 62 caspofungin 62 micrometastases 62 sirolimus eluting stent 62 NATRECOR ® 62 reoperation 62 lymphocytosis 62 fallopian tube cancers 62 FOLFOX6 62 thromboembolic complications 62 dacarbazine DTIC 62 virologic response 62 biliary tract cancer 62 tipranavir r 62 recurrent metastatic 62 febrile neutropenia 62 aminotransferases 62 ipsilateral breast 62 biologic DMARD 62 neurologic progression 62 idraparinux 62 epithelial ovarian 62 intact parathyroid hormone 62 invasive ductal 62 SHBG levels 62 leukocyte count 62 hormone receptor negative 62 dalteparin 62 Irinotecan 62 malignant lesions 62 mediastinoscopy 62 specific antigen PSA 61 neoadjuvant HT 61 non squamous NSCLC 61 segmentectomy 61 GISTs 61 nonischemic 61 postoperative AF 61 transthoracic 61 μg liter 61 recurrent GBM 61 interferon alfa 2b 61 letrozole 61 radical retropubic prostatectomy 61 abdominal hysterectomy 61 hip resurfacing arthroplasty 61 #mg/m# [001] 61 brain metastases 61 conventional angiography 61 HER2 expression 61 MGd 61 anthracycline taxane 61 neutrophil counts 61 carotid stenosis 61 seminal vesicle invasion 61 ritonavir boosted 61 total abdominal hysterectomy 61 pegylated liposomal doxorubicin PLD 61 proximal DVT 61 ductal lobular 61 antithrombotic therapy 61 CaP 61 squamous cell carcinoma SCC 61 subtrochanteric 61 serum prostate 61 hepatocellular carcinomas 61 morphometric vertebral fractures 61 axillary lymph node 61 p = NS 61 6 mercaptopurine 61 histologic subtype 61 VELCADE melphalan 61 renal cell carcinomas 61 salpingo oophorectomy 61 spinal cord compression 61 carotid endarterectomy CEA 61 T1c 61 5 Fluorouracil 61 carotid IMT 61 ovarian carcinoma 61 antiarrhythmic drugs 61 urodynamic 61 nonvertebral fractures 61 micafungin 61 4mg/kg 61 metastatic GIST 61 trans retinoic acid 61 neoplasias 61 esophagogastroduodenoscopy 61 standard chemotherapy regimen 61 mcg BID 61 venography 61 atorvastatin #mg 61 catheter angiography 61 ancrod 61 oblimersen 61 FOLFIRI alone 61 parathyroid 61 undergoing radical prostatectomy 61 mTOR inhibitors 61 directed thrombolysis 61 autologous SCT 61 CrCl 61 perioperative morbidity 61 Capecitabine 61 lopinavir r arm 61 hormone therapy estrogen 61 tocilizumab 61 melphalan prednisone 61 invasive lobular carcinoma 61 cinacalcet 61 peginterferon 61 recurrent NSCLC 61 mL/min/#.# m 2 61 MetS 61 adenoidectomy 61 ErbB2 positive 61 sonographically guided 61 fibrinolytic therapy 61 gastrectomy 61 varicocele 61 endosonography 61 ximelagatran 61 symptomatic VTE 61 transabdominal 61 thyroid nodules 61 NB UVB 61 taxane chemotherapy 61 IFN α 61 adalimumab 61 infarct size 61 Taxus Stent 61 insulin detemir 61 gastric cardia 61 nicardipine 61 octreotide 61 % CI #.#-#.# [007] 61 CIN3 + 61 atheroma volume 61 grade gliomas 61 tapentadol ER 61 oral antidiabetic medication 61 tumor histology 61 OGTT 61 core needle biopsy 61 histologically proven 61 transrectal ultrasound guided 61 interferon alfa 2a 61 primary patency 61 postintervention 61 duplex ultrasonography 61 isoproterenol 61 fluorouracil leucovorin 61 platelet inhibition 61 temozolomide TMZ 61 gastric adenocarcinoma 61 BCG refractory 61 serum PSA 61 intravesical 61 FDG-PET/CT 61 CRp 61 zoledronate 61 Navelbine 61 CK MB 61 doxorubicin cyclophosphamide 61 micrometastasis 61 sarcomatoid 61 completely resected 61 TMC# r 61 dose colchicine 61 piperacillin tazobactam 61 ASCT 61 Doppler sonography 61 detrusor 61 grade dysplasia 61 postoperative infections 61 Platinol 61 lung metastases 61 daily subcutaneous injections 61 progesterone receptor negative 61 cisplatin gemcitabine 61 TAXUS Express Stent 61 teriflunomide 61 salmeterol fluticasone 61 oral diclofenac 61 pimecrolimus 61 OPCAB 61 situ CIS 61 arterial thromboembolic events 61 Protelos 61 urothelial bladder cancer 61 serum PTH 61 tumor shrinkage 61 tolterodine ER 61 pancreatectomy 61 femoral neck fracture 61 AGILECT R 61 CR CRu 61 homozygotes 61 ribavirin RBV 61 chemotherapy cisplatin 61 CIMZIA ™ 61 anti androgen 61 rt PA 61 tumor necrosis 61 ERCP 61 sentinel node biopsy 60 #mmHg [001] 60 thromboembolic 60 docetaxel 60 VATS lobectomy 60 oxycodone CR 60 Preoperatively 60 metastatic renal cell carcinoma 60 myocardial reperfusion 60 serum TSH 60 dose clopidogrel 60 nmol liter 60 systemic corticosteroid 60 secondary efficacy endpoint 60 prognostic variables 60 postoperatively 60 % CI #.#-#.# [005] 60 D dimer 60 transvaginal sonography 60 acute GvHD 60 deep venous thromboses 60 saline placebo 60 virological response 60 conjugated equine estrogens 60 nonmelanoma skin cancers 60 thyroidectomy 60 % Confidence Interval 60 IV NSCLC 60 palifermin 60 trimethoprim sulfamethoxazole 60 patients undergoing CABG 60 QRS duration 60 serum urate 60 tenecteplase 60 radiographic progression 60 electrical cardioversion 60 gadobutrol 60 Retreatment 60 PegIFN RBV 60 resections 60 triiodothyronine 60 hamartomas 60 OAB symptoms 60 XIENCE V PROMUS Stent 60 bypass grafting 60 prostate TURP 60 PREZISTA ritonavir 60 photocoagulation 60 oral clodronate 60 abciximab 60 medically inoperable 60 CMV disease 60 ARIMIDEX 60 HER2 amplification 60 remission CR 60 Cystectomy 60 varices 60 Platinol ® 60 ICD shocks 60 care regimens CCR 60 trabectedin 60 multivariate analyzes 60 peritoneal cancer 60 intra arterial chemotherapy 60 iniparib 60 transaminase levels 60 paracentesis 60 thrombotic complications 60 fibroadenomas 60 mitomycin 60 antitumor effect 60 Postoperative complications 60 relapsed ovarian cancer 60 eplerenone 60 superficial bladder cancer 60 antimicrobial prophylaxis 60 postop 60 posttreatment 60 glargine 60 clinicopathological features 60 adenotonsillectomy 60 nondiabetic patients 60 GP IIb IIIa inhibitors 60 -#.# ± [002] 60 postoperative radiographs 60 Stent thrombosis 60 ropivacaine 60 folinic acid 60 NovoTTF 60 localized prostate cancer 60 antihypertensive therapy 60 elevated troponin 60 EDSS scores 60 nab paclitaxel 60 lenalidomide dexamethasone 60 follicular thyroid cancer 60 antiplatelet therapy 60 urography 60 fluvastatin 60 dose cyclophosphamide 60 laparotomy 60 intra arterial 60 GP IIb IIIa inhibitor 60 excisional biopsy 60 unfractionated heparin UFH 60 pg ml 60 nodular partial response 60 stage IIIb IV 60 clopidogrel Plavix 60 fluoropyrimidine 60 coronary artery stenosis 60 symptomatic paroxysmal AF 60 amenorrhoea 60 ER CHOP 60 mycophenolate mofetil MMF 60 undergone radical prostatectomy 60 HIPEC 60 elevated LDH 60 ATACAND 60 CI -#.# 60 renal insufficiency 60 docetaxel prednisone 60 inhibitor RG# 60 nodal dissection 60 paclitaxel Taxol 60 Multiple Myeloma MM 60 sleeve lobectomy 60 postmenopausal osteoporotic women 60 intradermal injection 60 paricalcitol 60 transaminase elevations 60 thymectomy 60 skeletal metastases 60 hemoglobin A1c levels 60 anthracycline therapy 60 Free Survival PFS 60 contrast induced nephropathy 60 metastases 60 cervical lymph nodes 60 kidney cysts 60 femoral neck BMD 60 primary aldosteronism 60 GI toxicity 60 atrioventricular block 60 pegylated interferon alfa 2b 60 antiarrhythmic drug 60 serum phosphorus 60 ureteroscopy 60 enucleation 60 optical colonoscopy 60 endarterectomy 60 mesalamine granules 60 A1c levels 60 liposomal doxorubicin 60 recurrent glioblastoma multiforme 60 TEAEs 60 thrombotic events 60 doxorubicin 60 NSTE ACS 60 TTF Therapy 60 bladder carcinoma 60 glycated hemoglobin levels 60 hepatocellular 60 cystoscopic 60 progression TTP 60 serum creatinine levels 60 warfarin therapy 60 somatostatin analog 60 Androgen deprivation therapy 60 undetectable PSA 60 LHRH receptor positive 60 rFVIIa 60 letrozole Femara 60 Exemestane 60 Pemetrexed 60 unresectable 60 pyrazinamide 60 HER2 overexpression 60 urinary symptoms 60 tamoxifen Nolvadex ® 60 lobular cancer 60 genotypic resistance 60 intratumoral 60 lipid lowering therapy 60 Fontan procedure 60 postprocedure 60 DAS# remission 60 partial remissions 60 paragangliomas 60 variceal bleeding 60 immunomodulatory therapy 60 aPTT 60 #ng/ml 60 mg QD 60 CIMZIA TM 60 neointimal hyperplasia 60 pertuzumab 60 fondaparinux 60 cranial radiation 60 endocrine therapies 60 neoplasm 60 functional mitral regurgitation 60 prospectively defined 60 microg 60 ketorolac 60 CIN2 60 grade glioma 60 rhGH 60 polyp detection 60 partial nephrectomy 60 neoplasms 60 pmol L 60 HER2 positive metastatic breast 60 mucinous 60 penetrating keratoplasty 60 Radiofrequency ablation 60 â ‰ ¥ 60 DOXIL ® 60 invasive candidiasis 60 response pCR 60 laparoscopically assisted 60 hamartoma 60 malignant neoplasms 60 palliation 60 postoperative hemorrhage 60 cutaneous squamous cell carcinoma 60 antibiotic prophylaxis 60 multivariate Cox 60 ALT elevations 60 aortic root replacement 60 B7 H3 60 symptomatic benign prostatic 60 dose Iluvien 60 sacrocolpopexy 60 myeloablative 60 hypercalcemia 60 treated nonsurgically 60 Gliadel Wafer 60 neoadjuvant radiation 60 nadroparin 60 HbA 1c levels 60 intracranial hemorrhage ICH 60 PCWP 60 infliximab monotherapy 60 advanced neoplasia 60 irinotecan chemotherapy 60 thromboembolism 60 sirolimus stent 60 transrectal 60 Femara letrozole 60 esomeprazole 59 SCr 59 VFEND 59 titrated glipizide 59 ribavirin therapy 59 severe exacerbations 59 intraoperative complications 59 comorbidities 59 refractory ischemia 59 varicoceles 59 hypofractionated 59 paraprotein 59 peg interferon 59 polypectomy 59 chlamydial infection 59 ovulation induction 59 vincristine doxorubicin 59 8mg/kg 59 gonadotropin releasing hormone 59 endometrial biopsy 59 ULORIC 59 laser photocoagulation 59 anticoagulation therapy 59 cilengitide 59 FSAD 59 lobular carcinomas 59 histological subtype 59 atrial pacing 59 invasive aspergillosis 59 esophageal carcinoma 59 Heavy menstrual bleeding 59 hypofractionated radiation 59 intrathecal chemotherapy 59 HDR brachytherapy 59 transitional cell carcinoma 59 mCRC patients 59 ejection fractions 59 Acute Myeloid Leukaemia AML 59 leukopenia 59 hypertrophic scars 59 autologous chondrocyte implantation 59 bone scintigraphy 59 lung metastasis 59 underwent surgical resection 59 topotecan 59 colorectal metastases 59 lymphocyte count 59 allogeneic HSCT 59 FluCAM arm 59 cerebral angiography 59 temozolomide 59 multivariable analysis 59 posaconazole 59 Tumor shrinkage 59 gastric pH 59 lipid lowering drugs 59 eribulin 59 post thrombotic syndrome 59 refractory prostate cancer 59 mg m² 59 abiraterone acetate 59 Acute Coronary Syndromes ACS 59 isoenzyme 59 tamoxifen 59 bone metastasis 59 docetaxel Taxotere 59 neostigmine 59 Fludarabine 59 amenorrhea 59 TNF α 59 prostate cancer HRPC 59 spontaneous bacterial peritonitis 59 imipenem 59 transarterial chemoembolization 59 polyp recurrence 59 serum phosphate levels 59 creatinine clearance 59 serum testosterone levels 59 medroxyprogesterone acetate 59 repigmentation 59 #mg dose [001] 59 liposomal amphotericin B 59 moderately emetogenic 59 cabazitaxel 59 hyperplasia BPH 59 mIU ml 59 gastroesophageal junction 59 mRNA expression